Impacts of Resistance Training on Acute Secretion of Irisin in Obese Older and Young Adults

Obesity Clinical Trial

Official title:

Impacts of Resistance Training on Acute Secretion of Irisin in Obese Older and Young Adults

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03715088
• Other study ID #: UNB Fredericton
• Status: Completed
• Phase: N/A
• Start date: May 2016
• Est. completion date: August 2016

Study information

• Verified date: June 2018
• Source: University of New Brunswick
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

It is established that resistance training improves metabolic health; however, the mechanisms of this process are not fully understood. A biologically active substance, irisin, has recently received interest in the scientific community with respect to its effects on energy expenditure and weight loss. The purpose of this study is to compare the different irisin release response during a resistance exercise training session. The study will compare individuals two different age groups (young adults: age 18-30; older adults: age 65-75) living with obesity.

Description:

Background: Worldwide, the number of individuals living with obesity has doubled over the past thirty years. The growing prevalence of obesity is concerning as obesity is known to be one of the main risk factors for many chronic conditions, such as Type 2 diabetes and cardiovascular diseases. Therefore, it is important that the impact of different types of exercise are understood to properly prescribe exercise interventions to individuals living with obesity. Recently, there has been increased interest for a biologically active substances that are secreted during muscle contraction, myokines, regarding their effects on metabolism during exercise. Specifically, a novel myokine, named irisin, has caught the attention of numerous researchers. Irisin has been shown to play an important role in increasing energy expenditure, reducing body weight, and improving glucose metabolism by adipocyte metabolism. As of now, the majority of research has focused on irisin release during endurance activity; however, there is limited research on irisin secretion during resistance exercise training.

Statement of Objectives: The purpose of this pilot study is to first determine whether irisin secretion increases during an acute session of resistance exercise training with obese individuals; and second, to determine whether changes in irisin levels during an acute bout of resistance exercise training can be seen in different age groups for obese individuals.

Methodology: Fifteen young and fifteen old participants will be recruited via advertisement in the local newspaper, on radio stations, and on posters. Inclusion criteria include individuals aged between either 18-30 or 65-75 years old, classified as obese according to their BMI (>30 kg/m2), inactive defined as engaging in less than 150 minutes of moderate to vigorous aerobic exercise, not currently engaged in a resistance exercise training program, no previous diagnosis of Type 2 diabetes, and having no injuries or conditions that would prevent them from performing a resistance exercise training session.

Primary Outcome Measure: The primary outcome measure in this study will be the change in irisin levels during resistance exercise training. A validated enzyme immunoassay kit from Phoenix Pharmaceutical Inc. (EK-067-16) will be used to measure irisin. Our group already has experience with this equipment and these procedures, which has been validated.

Resistance Exercise Session: Participants will come for their first visit at which time they they will perform a test to determine their maximal strength [1-repetition maximal (1-RM)] for each exercise included in the program. During their second visit, participants will perform 10 different resistance exercises consisting of three sets of 8-10 repetitions, at 80% of 1-RM. A 60-second rest will occur between sets. This exercise protocol was selected based on literature that suggests that the protocol and the intensity do not enhance mitochondria biogenesis. Also, this protocol was shown to be well tolerated by obese and older individuals.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 31
• Est. completion date: August 2016
• Est. primary completion date: August 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Age between 18-35 or 60-75 years old

• Physically inactive (engaging in less than 150 minutes of moderate to vigorous aerobic exercise)

• No previous diagnosis of Type 2 diabetes

• Obese (BMI =30kg/m2)

Exclusion Criteria:

• BMI less than 30kg/m2

• History of Type 2 diabetes

• Physically active (engaging in atleast 150 minutes of moderate to vigorous aerobic exercise)

• Injury or condition that prevents performance of resistance training exercise.

Related Conditions & MeSH terms

• Obesity

Intervention

Behavioral:
• Resistance Training Intervention
Participants will perform 10 different resistance exercises consisting of three sets of 8-10 repetitions, at 80% of 1-RM, separated by 60-second rest intervals between sets. This exercise protocol was chosen based on literature that suggests that the protocol and intensity do not enhance mitochondria biogenesis. Also, it was well tolerated by obese and older individuals.

Locations

Country	Name	City	State
Canada	University of New Brunswick - Kinesiology	Fredericton	New Brunswick

Sponsors (1)

Lead Sponsor	Collaborator
University of New Brunswick

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Irisin	The primary outcome is the change in irisin during an acute bout of resistance exercise training.	Baseline (0 minute), 15 minutes, 30 minutes, and 45 minutes during exercise and 45 minutes post exercise